FCH
CELG

Freestone Capital Holdings’s Celgene Corp CELG Stock Holding History

Freestone Capital Holdings’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2,738
Closed -$258K – 396
2019
Q1 		$258K Sell
2,738
-18,098
-87% -$1.58M 0.02% 325
2018
Q4 		$1.34M Sell
20,836
-27,759
-57% -$2.05M 0.09% 184
2018
Q3 		$4.35M Buy
48,595
+13,155
+37% +$1.16M 0.03% 118
2018
Q2 		$2.81M Buy
+35,440
New +$2.94M 0.02% 137

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Freestone Capital Holdings's CELG Position: Q2 2019 in Review

Freestone Capital Holdings sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 2,738 shares — an estimated $258K sold.

Freestone Capital Holdings first reported a position in CELG in Q2 2018 and held it in 4 quarters. The position peaked at $4.35M in Q3 2018. 1,287 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

  • Freestone Capital Holdings reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
  • Freestone Capital Holdings sold 2,738 Celgene Corp shares in Q2 2019, an estimated $258K.
  • Freestone Capital Holdings first reported a position in Celgene Corp in Q2 2018 and held it in 4 quarters.
  • Freestone Capital Holdings's Celgene Corp position peaked at $4.35M in Q3 2018.
  • 1,287 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Freestone Capital Holdings's 13F filing for Q2 2019, filed 5 Aug 2019.